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A total of 128 Streptococcus pneumoniae isolates that were susceptible to penicillin but resistant to non--
lactam agents were isolated from young carriers in Greece and analyzed by antibiotic susceptibility testing,
serotyping, restriction fragment end labeling (RFEL), and antibiotic resistance genotyping. The serotypes 6A/B
(49%), 14 (14%), 19A/F (11%), 11A (9%), 23A/F (4%), 15B/C (2%), and 21 (2%) were most prevalent in this
collection. Of the isolates, 65% were erythromycin resistant, while the remaining isolates were tetracycline
and/or trimethoprim-sulfamethoxazole resistant. Fifty-nine distinct RFEL types were identified. Twenty dif-
ferent RFEL clusters, harboring 2 to 19 strains each, accounted for 76% of all strains. Confirmatory multilocus
sequence typing analysis of the genetic clusters showed the presence of three international clones
(Tennessee23F-4, England14-9, and Greece6B-22) representing 30% of the isolates. The erm(B) gene was present
in 70% of the erythromycin-resistant isolates, whereas 18 and 8% contained the mef(A) and mef(E) genes,
respectively. The pneumococci representing erm(B), erm(A), and mef genes belonged to distinct genetic clusters.
In total, 45% of all isolates were tetracycline resistant. Ninety-six percent of these isolates contained the tet(M)
gene. In conclusion, penicillin-susceptible pneumococci resistant to non--lactams are a genetically heteroge-
neous group displaying a variety of genotypes, resistance markers, and serotypes. This suggests that multiple
genetic events lead to non--lactam-resistant pneumococci in Greece. Importantly, most of these genotypes are
capable of disseminating within the community.
Streptococcus pneumoniae is a common cause of invasive
diseases, such as meningitis and bacteremia, and of respiratory
tract infections (5). S. pneumoniae isolates that are resistant to
penicillin and/or non--lactam agents have been frequently
reported (6, 12, 35). Resistance of S. pneumoniae to erythro-
mycin and the other macrolides is increasing in many parts of
the world (15, 17). Strains resistant to erythromycin are also
resistant to azithromycin, clarithromycin, and roxithromycin
(37). This global increase in antibiotic-resistant and especially
multidrug-resistant pneumococci is the result of the spread of
various highly resistant pneumococcal clones (7, 25).
In Greece, the emergence of antibiotic resistance among
pneumococcal isolates was recognized in the mid-1990s (30).
Recently, pneumococcal isolates susceptible to penicillin and
resistant to chloramphenicol, tetracycline, erythromycin, clin-
damycin, and trimethoprim-sulfamethoxazole (SXT) have
been isolated from young Greek carriers. During the period
from December 1995 to February 1996, 24% of the pneumo-
cocci isolated from healthy carriers attending day care centers
were demonstrated to be penicillin-susceptible, non--lactam-
resistant isolates (29). In a recent study in which 2,448 children
younger than 2 years old living in various areas in Greece were
screened during a 2-year period (1997 to 1999) for pneumo-
coccal carriage, 15% of the pneumococci appeared to have
reduced susceptibility to non--lactam agents (31).
The present study was undertaken to investigate the molec-
ular epidemiological characteristics of the Greek pneumococci
susceptible to penicillin but resistant to erythromycin and/or
other non--lactam agents. Furthermore, penicillin, erythro-
mycin, and tetracycline resistance determinants were studied at
a molecular level.
MATERIALS AND METHODS
Bacterial isolates. We studied a collection of 128 S. pneumoniae isolates
susceptible to penicillin but resistant to erythromycin and/or other non--lactam
agents; the isolates were recovered from nasopharyngeal cultures obtained from
children during two independent studies in Greece (3, 30, 31). The first study was
performed in 338 children attending seven day care centers in the city of Patras
in southwestern Greece during the 2-month period from December 1995 to
February 1996. In this study, 30 penicillin-susceptible pneumococci resistant to
one or more non--lactam agents were recovered from 132 carriers. Of these 30
S. pneumoniae isolates, 26 were available for further analysis in the present
investigation. The second study, the Hellenic Antibiotic-Resistant Respiratory
Pathogens (HARP) study, was conducted from February 1997 to February 1999.
Nasopharyngeal cultures for S. pneumoniae were performed in 2,448 children
younger than 2 years old living in central and southern Greece. Ninety-five
(3.9%) of the 2,448 children attended day care centers. In the HARP study,
screening of the children revealed 119 pneumococci which were penicillin sus-
ceptible but resistant to non--lactam agents. Of these 119 pneumococci, 102
were available for further analysis. Thirteen of these pneumococci were isolated
from children attending day care. Only two of these children attended the same
day care center.
Bacteriological procedures. Isolation, identification, and susceptibility testing
of the Greek S. pneumoniae isolates were performed by applying standard meth-
ods as described previously (30, 31). Penicillin and erythromycin MICs for the
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Greek isolates were determined by the E-test method (AB Biodisk, Solna,
Sweden). Susceptibility to clindamycin, chloramphenicol, tetracycline, and SXT
was determined by the disk diffusion method according to the guidelines of the
National Committee for Clinical Laboratory Standards (NCCLS) (21). Multi-
drug resistance was defined as resistance to three or more classes of antimicro-
bial agents. Pneumococci were serotyped by the capsular swelling method or the
latex agglutination technique (30, 33).
Penicillin-binding protein (PBP) genotyping. Genetic polymorphism of the
penicillin resistance genes pbp1a, pbp2b, and pbp2x of the pneumococcal isolates
was investigated by restriction fragment length polymorphism (RFLP) analysis of
the PCR-amplified genes, as described previously (13).
Detection and analysis of the erm(B) and mef genes. To detect the presence of
erm(B) within the pneumococcal isolates, we used the protocol of Sutcliffe et al.
(28). In summary, we amplified the genes by PCR and analyzed the amplified
DNA products by agarose gel electrophoresis. The presence of the mef gene was
also detected by PCR (28). In order to discriminate between mef(A) and mef(E),
PCR-RFLP analysis was performed by the method of Del Grosso et al. (8). The
amplicon was digested using BamHI and DraI. The mef(A) gene contains a single
BamHI site, which is absent in the mef(E) gene. Digestion of mef(A) and mef(E)
with DraI yields two and three fragments, respectively.
Detection of the tet(M) and tet(O) genes. In order to discriminate between
tet(M) and tet(O), a PCR-RFLP analysis was performed as described previously
(2). In summary, a PCR mix was made of 25-l reaction buffer containing 0.5 U
of thermostable DNA polymerase, diluted in the buffer supplied by the manu-
facturer (Integro, Leuvenheim, The Netherlands), 0.2 mM (each) deoxynucleo-
side triphosphate, 1.5 mM MgCl2, 10 pmol of each primer, and 10 to 50 ng of
pneumococcal DNA. Amplification cycling in a programmable thermal control-
ler (PTC-100; MJ Research, Watertown, Mass.) consisted of the following steps:
predenaturation for 1 min at 94°C, followed by 30 cycles, with 1 cycle consisting
of 1 min at 94°C, 1 min at 57°C, and 1 min at 72°C. Amplification was finished
after 3 min at 72°C. A 1.5% agarose gel in 0.045 M Tris-borate buffer with 0.001
M EDTA (0.5 TBE buffer) containing 0.1 g of ethidium bromide per ml was
used to visualize the PCR products.
RFEL typing. Pneumococcal strain typing by restriction fragment end labeling
(RFEL) was performed by the method of van Steenbergen et al. (36) as adapted
by Hermans et al. (13). Briefly, purified pneumococcal DNA was digested by the
restriction enzyme EcoRI. The DNA restriction fragments were end labeled at
72°C with [-32P]dATP using DNA polymerase (Goldstar; Eurogentec, Seraing,
Belgium). After the radiolabeled fragments were denatured and separated elec-
trophoretically on a 6% polyacrylamide sequencing gel containing 8 M urea, the
gel was transferred onto filter paper, vacuum dried (HBI, Saddlebrook, N.Y.),
and exposed for variable times at room temperature to ECL hyperfilm (Amer-
sham Laboratories, Amersham, United Kingdom).
Computer-assisted analysis of DNA band patterns. RFEL autoradiographs
were converted to images (Image Master DTS; Pharmacia Biotech, Uppsala,
Sweden) and analyzed with a computer (Windows version Gelcompar software
version 4; Applied Math, Kortrijk, Belgium). DNA fragments were analyzed as
described previously (26). For evaluation of the genetic relatedness of the iso-
lates, we used the following definitions: (i) isolates of a particular RFEL type are
100% identical by RFEL analysis; (ii) an RFEL cluster represents a group of
RFEL types that differ in only one band (approximately 95% genetic related-
ness); (iii) an RFEL lineage represents a group of RFEL types that differ in less
than four bands (approximately 85% genetic relatedness).
International comparison. The Greek genotypes were compared with an in-
ternational collection of pneumococcal isolates representing 751 distinct RFEL
types originating from 17 different countries in America, Europe, Africa, and
Asia (2, 12;M. Sluijter, unpublished observations). The international collection
includes the first 16 international pandemic clones described by the Pneumococ-
cal Molecular Epidemiological Network in 2000 (http://www.pneumo.com/physician
/pmen_clone_collection.asp) (18).
MLST. The genotypes of all clusters were verified by multilocus sequence
typing (MLST) analysis. For this purpose, a fully automated method for MLST
was used as described previously (14), and one or two isolates per cluster were
analyzed. The MLST types were compared with the global database at www
.mlst.net.
RESULTS
The serotypes 6A/B (49%), 14 (14%), 19A/F (11%), 11A
(9%), 23A/F (4%), 15B/C (2%), and 21 (2%) were most prev-
alent in the collection of 128 Greek pneumococcal isolates. All
isolates were invariably susceptible to penicillin, while 84
(65%), 78 (60%), 69 (54%), 63 (49%), and 62 (48%) isolates
were resistant to erythromycin, SXT, tetracycline, chloram-
phenicol, and clindamycin, respectively.
The isolates were classified as penicillin-susceptible erythro-
mycin-resistant (65%) and penicillin-susceptible erythromycin-
susceptible (35%) isolates. The latter group was represented
by tetracycline- and/or SXT-resistant pneumococci. The 84
penicillin-susceptible erythromycin-resistant pneumococci dis-
played capsular types 6B (56%), 14 (18%), 19F (13%), 11A
(11%), 10A (1.2%), and 15C (1.2%). Of these erythromycin-
resistant isolates, 59 (70%), 15 (18%), and 7 (8.3%) isolates
carried the erm(B), mef(A), and mef(E) erythromycin resis-
tance determinants, respectively. In four erythromycin-resis-
tant isolates belonging to a serotype 11A clone, an erm(A)
gene was previously detected (32). Furthermore, 62 (74%), 57
(68%), 46 (55%), and 42 (50%) of the 84 penicillin-susceptible
erythromycin-resistant pneumococci, were also resistant to
clindamycin, tetracycline, SXT, and chloramphenicol, respec-
tively. Clindamycin resistance was always identified in combi-
nation with erythromycin resistance. All 62 clindamycin- and
erythromycin-resistant isolates carried an erm resistance gene.
Of the 54 erythromycin-resistant isolates that were resistant to
tetracycline, 51 carried the tet(M) resistance gene. The three
remaining isolates were negative for both the tet(M) and tet(O)
genes.
The 44 penicillin-susceptible erythromycin-susceptible iso-
lates belonged to serotypes 6B (29%), 23F (11%), 14 (6.7%),
21 (6.7%), 1 (4.4%), 6A (4.4%), 15B (4.4%), 18C (4.4%), 19A
(4.4%), 8 (2.2%), 10A (2.2%), 11A (2.2%), 16F (2.2%), 19F
(2.2%), 20 (2.2%), and 24F (2.2%) and nontypeable serotypes
(4.4%).
Sulfamethoxazole resistance was identified in 34 of the 44
penicillin-susceptible erythromycin-susceptible isolates (78%),
whereas tetracycline resistance was identified in 12 (27%) iso-
lates. All but one carried the tet(M) resistance gene. All iso-
lates were resistant to a single agent except for one isolate that
was resistant to tetracycline and chloramphenicol and two iso-
lates that were resistant to tetracycline and SXT.
Fourteen distinct PBP genotypes were observed. Of the 128
isolates, 76 (59%), 24 (19%), and 4 (3.1%) displayed a known
penicillin-susceptible PBP 1A-2B-2X genotype, being 2-2-71,
2-2-3, and 2-2-2, respectively. The remaining isolates displayed
FIG. 1. Dendrogram of the 59 RFEL types observed among the 128 Greek S. pneumoniae nasopharyngeal isolates. The molecular sizes of
reference bands (in bases [b]), serotypes, PBP types, RFEL types, MLST types, number of isolates per RFEL type, clusters, and cluster codes are
depicted. One or two strains per RFEL clusters were analyzed by MLST. Day care center isolates from the 1995 to 1996 study (asterisks) and day
care center isolates from the 1997 to 1999 study (degree symbols) are indicated. If more than one day care center isolate belongs to a specific
genotype, the total number is displayed in parentheses. Two new strains with new MLST types (new1 and new2) are indicated. These two strains
have been submitted to the MLST database. nt, nontypeable.
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alterations in pbp2x (11 distinct types), pbp2b (2 types), and
pbp1a (1 type).
RFEL analysis divided the 128 penicillin-susceptible iso-
lates, which were resistant to one or more non--lactam agents
into 59 distinct RFEL genotypes (Fig. 1). Ninety-nine isolates
belonged to 20 genetic clusters, representing 77% of the iso-
lates and varying in size from 2 to 19 isolates (Table 1). The
average cluster size was 5.0 isolates. Five of the 20 clusters
contained two serotypes, while the remaining clusters con-
tained only one serotype each. The 20 clusters belonged to 11
lineages. The three largest clusters were cluster III, XVI, and
XVII. Cluster III consisted of 13 (10%) isolates and was iden-
tical to the pandemic clone England14-9 which was confirmed
by MLST analysis (Fig. 1 and Table 1). This cluster belonged
to a single predominant lineage of 14 genetically related iso-
lates, representing three RFEL genotypes and harboring the
serotypes 11A, 14, and 18C. The serotype 14 pneumococci
carried the mef(A) erythromycin resistance determinant and
had a low to moderate level of resistance to erythromycin. The
remaining pneumococci were resistant to SXT.
Clusters XVI (19 isolates) and XVII (11 isolates) belonged,
together with cluster XIV (6 isolates) and XV (2 isolates), to
one predominant lineage, representing 10 RFEL types and all
harboring the serotype 6B. Most isolates were resistant to
erythromycin, clindamycin, tetracycline, chloramphenicol, and
SXT. These pneumococci carried the erm(B) erythromycin
resistance determinant and had a high level of resistance to
erythromycin. The latter clusters were identical to the pan-
demic clone Greece6B-22 and closely related to the penicillin-
resistant MDR clone Spain6B-2 that has spread from Spain to
Iceland in the late 1980s (29).
Clusters I (three isolates) and XIX (three isolates) repre-
sented genotypes identical to the pandemic clone Tennessee23F-4
and closely related to the pandemic clone Spain9V-3 (six of
seven alleles) as described by the Pneumococcal Molecular
Epidemiology Network. The genetic relatedness of the ob-
served MLST profiles of the 20 RFEL clusters is depicted in
Fig. 2.
The 39 isolates recovered from children attending day care
centers displayed 21 different genotypes; 10 isolates displayed
unique genotypes, whereas the remaining 29 isolates displayed
13 genotypes belonging to 11 clusters. Cluster XVI contained
nine isolates from one day care center, whereas cluster XVII
contained three isolates from a second single day care center.
TABLE 1. Molecular and phenotypic characteristics of the 129 Greek pneumococcal isolates
RFEL
cluster
No. of isolates/no.
of RFEL types
Serotype (no.
of strains)
Resistance patterna
(no. of strains)
PBP type (no.
of strains)
Genotype
(no. of strains)
I 4/2 23F (4) S 2-2-3
II 2/1 19F (2) TECLS 2-2-3 erm(B), tet(M)
ECLS erm(B)
III 13/2 14 (13) E (13) 2-2-71 mef(A)
IV 2/1 15B S 2-2-44
15C ECL 2-2-3 erm(B)
V 7/2 11A (6) TECL (4) 2-2-3 (6) erm(B) (4), tet(M) (4)
14 (1) S (2) 2-2-71 (1) mef(E) (1)
E (1)
VI 4/1 11A (4) TECL 2-2-3 erm(A), tet(M)
VII 7/2 6B (7) S (6) 2-2-71 erm(B) (1), tet(M)(1)
E (1) mef(E)
VIII 2/1 6B (2) S (2) 2-2-71
IX 2/1 6B (2) CTECLS 2-2-71 Unknown
S
X 2/1 14 (2) S (2) 2-2-71
XI 3/1 21 S (3) 2-2-7
2-2-98
XII 2/1 19F (2) TECL 2-2-98 erm(B) (2)
tet(M) (2)
XIII 4/2 6B (2) T (3), TS (1) 2-5-22 (2) tet(M) (4)
6A (2) 2-5-99 (1)
2-2-71 (1)
XIV 6/2 6B (6) CTECLS (5) 2-2-71 erm(B) (6)
CTECL tet(M) (6)
XV 2/2 6B (2) CTECLS 2-2-71 erm(B) (2)
CTECL tet(M) (2)
XVI 19/2 6B (19) CTECLS (17) 2-2-71 (18) erm(B) (19)
CTECL (1) 0-0-0 (1) tet(M) (18)
TECLS (1)
XVII 11/1 6B (11) CTECLS (11) 2-2-71 (10) erm(B) (11)
0-0-0 (1) tet(M) (11)
XVIII 2/2 10A TECL (1) 2-2-71 erm(B) (1), tet(M) (1)
S 2-2-2
XIX 4/2 19F (4) E 2-2-2 (4) met(A) (1)
met(E) (3)
XX 2/1 19F (1) S 2-2-2 (1)
24F (1) 2-2-3 (1)
a Abbreviations: C, chloramphenicol; T, tetracycline; E, erythromycin; CL, clindamycin; S, trimethoprim-sulfamethoxazole.
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The remaining clustering day care center isolates originated
from different day care centers (Fig. 1).
DISCUSSION
We evaluated 128 S. pneumoniae isolates that were suscep-
tible to penicillin but resistant to non--lactam agents from
young carriers in Greece by antibiotic susceptibility testing,
serotyping, RFEL, and antibiotic resistance genotyping. In
general, the isolates could be divided into two groups: one
group consisting of 84 erythromycin-resistant isolates, while
the second group of 44 isolates were erythromycin susceptible.
Multidrug resistance, i.e., resistance to three or more different
classes of antibiotics, was seen predominantly within the first
group of isolates, whereas the erythromycin-susceptible iso-
lates predominantly displayed monodrug resistance to tetracy-
cline or sulfamethoxazole. Furthermore, clustering of isolates,
which is the result of horizontal spread of the isolates within
the community, was higher among multidrug-resistant geno-
types. This is in line with previous findings where multidrug-
resistant clones have shown to spread from country to country
(3, 4, 7, 20, 22, 25, 27, 35). This has led to the classification of
pandemic clones by the Pneumococcal Molecular Epidemio-
logical Network (18). Although the majority of these pandemic
clones are penicillin resistant, our study as well as previous
studies have shown that this is not a prerequisite for clonal
spread.
With emerging non--lactam resistance among pneumo-
cocci, the spread of penicillin-susceptible non--lactam-resis-
tant pneumococci has become apparent (1, 24, 29, 34). This is
underlined by our observation that, in addition to one large
lineage of serotype 6B isolates that were mostly susceptible to
penicillin and resistant to erythromycin, tetracycline, chloram-
phenicol, and sulfamethoxazole, 16 smaller clusters were found.
In total, 30% of the isolates displayed a genotype identical to
those of the pandemic clones Tennessee23F-4, England14-9, and
Greece6B-22 as reported by the Pneumococcal Molecular Epide-
miological Network. These findings clearly indicate heterogeneity
among the penicillin-susceptible, non--lactam-resistant isolates.
Furthermore, these clusters represent not only the conjugate vac-
cine serotypes 6B, 14, 19F, and 23F, but also non-vaccine sero-
types, such as 11A, 15B/C, and 21. This observation implicates
that non-vaccine serotypes are also able to spread among chil-
dren; hence, vaccination with pneumococcal conjugate vaccines is
not a solution for the emergence of multidrug resistance among
pneumococcal isolates.
In this study, 70% of the erythromycin-resistant isolates har-
bored the erm(B) gene, while 18 and 8% of the isolates con-
tained mef(A) and mef(E) genes, respectively. These data dif-
fer from previous findings made by Reinert and coworkers,
who observed an almost equal distribution of erm(B) (43%)
and mef(E) (56%) genes among erythromycin-resistant iso-
lates in Germany (23). However, our data are in line with a
recent study performed in Italy and Vietnam where the ma-
jority of the strains also displayed the erm(B) gene (2, 19). In
the four low-level erythromycin-resistant isolates displaying an
identical RFEL genotype and serotype 11A, the erm(A) gene
was previously identified (32).
Genetic analysis of tetracycline resistance genes tet(M) and
tet(O) revealed that the tet(M) gene was exclusively observed in
91% of the Greek isolates. This is in line with the Viet-
namese study where the tet(M) gene was also exclusively ob-
served (2). In contrast to other studies, the remaining tetracy-
cline-resistant isolates did not harbor the tet(O) gene (16). So
far, no other tetracycline resistance determinants have been
FIG. 2. Genetic relatedness of the 15 MLST sequence types (ST) observed within the 20 RFEL clusters.
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described; therefore, the underlying mechanism remains un-
clear. Also in line with the Vietnamese study is the isolation of
tet(M)-containing but tetracycline-susceptible strains in
Greece, suggesting the presence of a nonfunctional or unex-
pressed tetracycline resistance gene (2, 9). A similar phenom-
enon was seen for the PBP genes. Though the majority of the
isolates displayed (known) susceptible genotypes, 10% of the
isolates displayed alterations in one or two of the three major
PBP genes, pbp1a, pbp2b, and pbp2x, which often implicates
intermediate penicillin resistance (10). In our study, the ob-
served alterations in pbp1a, pbp2b, and four of the pbp2x al-
terations were identified previously in non-penicillin-suscepti-
ble pneumococci isolated in Thailand, the United States, and
The Netherlands (11). Although these alterations have shown
to be related to intermediate susceptibility, in all cases an
additional alteration in one or two of the PBP genes was
present (Sluijter, unpublished). These findings support the hy-
pothesis that not all genetic alterations lead to amino acid
substitutions or to substitutions which are relevant for penicil-
lin resistance.
We hypothesize that the ongoing antibiotic pressure will
continue the process of alteration and spread of resistance
genes among pneumococci. Our study underlines that antibi-
otic resistance in any form and irrespective of its serotype is of
benefit for S. pneumoniae with respect to survival and spread in
the community. This implies that despite the introduction of
new and effective pneumococcal conjugate vaccines, restrictive
use of antibiotics will be of major importance.
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